When Words Are Not Enough
Description:
One in four women will experience clinical depression, anxiety, or premenstrual depression in her lifetime. The good news is that popular new prescription drugs like Prozac and Xanax bring much needed relief. The bad news is that many physicians and therapists are unaware of common issues for women. As medical treatment for depression and anxiety has become simpler, more and more general practitioners are prescribing antidepressants, often with little background in the nonmedical alternatives or complex mind-body interactions.
Emphasizing women's family roles as well as their unique biological/hormonal sensitivities, Dr. Raskin explains contemporary integrated treatment options. Raskin pays special attention to how birth control, menstrual cycles, childbearing, and menopause impact treatment choices. Raskin empowers women to take an active approach in dealing with common side effects, including weight gain and diminished sexual responsiveness. Using revealing case studies, Raskin offers a wealth of hands-on advice.
At a time when trends in health care have led to less personalized contact between doctor and patient, When Words Are Not Enough provides the facts and reassurance women need to be in control of their own health.
Best prices to buy, sell, or rent ISBN 9780553067132
Frequently Asked Questions about When Words Are Not Enough
The price for the book starts from $5.35 on Amazon and is available from 28 sellers at the moment.
If you’re interested in selling back the When Words Are Not Enough book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the When Words Are Not Enough book, the best buyback offer comes from and is $ for the book in good condition.
The When Words Are Not Enough book is in very low demand now as the rank for the book is 5,273,754 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.